Peer Review History

Original SubmissionNovember 8, 2020
Decision Letter - Alexander MacKerell, Editor, Arne Elofsson, Editor

Dear Dr. Gräter,

Thank you very much for submitting your manuscript "How multisite phosphorylation impacts the conformations of intrinsically disordered proteins" for consideration at PLOS Computational Biology.

As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Alexander MacKerell

Associate Editor

PLOS Computational Biology

Arne Elofsson

Deputy Editor

PLOS Computational Biology

***********************

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: Very timely problem, addressed in a very rigorous manner. Owing to the relevance of the phenomenon studied and the number of not sufficiently careful computational studies on the field, the reviewer is grateful to the authors that they 'pour clean water into the glass'.

Minor comments:

- For general audience, it would be useful to prepare a scheme summarising the effect of phosphorylation in disordered or partly structured domains based on your findings and previous results of others. Can you elaborate the potential mechanisms in the intro, as well?

- The impact of phosphorylation also depends on to what extent the ID chains get ordered upon binding. Can you elaborate this aspect, in particular in the lights of how phosphorylation can screen protein-protein interactions (autoinhibitory effects)?

I can give a long list of citations of experimental studies eg. on Max, Ets-1, Ire-1, FACT etc., summarised in reviews on fuzzy complexes.

- I appreciate the large-scale study on different FFs. Can you detail the polarisation effect, solvent models and maybe sampling factors?

- Application to biomolecular condensates. It is good that you mention this, but would be worth to mentioning in intro. Not only dynamic condensates but formation of many different kinds of higher-order assemblies are regulated by phosphorylation (see Wu& Fuxreiter Cell 2016). The question is then, how the screening effect of phosphorylation which you describe relates to the interactions in 'traditional' assemblies and protein droplets. This is a crucial point to allocate the sites of regulation for biomolecular condensates.

Reviewer #2: In their manuscript “How multisite phosphorylation impacts the conformations of

intrinsically disordered proteins”, Jin and Gräter describe a systematic study in which they use extensive molecular dynamics simulations to characterize the effects of phosphorylation on the structure of IDPs of different amino acid composition. From Table 2 of the SI (list of simulations), it is clear that their study has covered a variety of sequences (Ash1, E-Cadherin, CTD2’ and p130Cas), phosphorylation states, salt concentrations and force fields, for a total sampling time of 0.272 ms. The manuscript is clear and understandable, and the authors have carried out a careful study on an important and current problem in the field of IDPs.

I have some suggestions for revision that could strengthen the manuscript and some questions about details in the manuscript:

- In the introduction, it would be relevant to mention recent work from the Skepö lab (https://pubs.acs.org/doi/abs/10.1021/acs.jctc.9b01190) on the effect of phosphorylation on the conformation of another IDP - statherin. This work looks at a similar problem as this manuscript.

- Table 1 — it would be helpful to provide the Genbank accession numbers for the sequences because it is unclear what species they are from.

- On p. 8 line 145, the authors cite ref. 25 for the statement “Given that the current protein force fields have been shown to overstabilize electrostatic interactions“, but as far as I can tell, reference 25 doesn’t support that statement. Similarly in lines 150-152.

- The authors suggest that salt bridges are overstabilized based on differences in Rg (p. 8, line 150-152). Rg is an global feature. This statement could be supported quantitatively by providing populations of salt bridges in the simulations with differing salt concentrations.

- When comparing to SAXS/NMR measurements, it would be useful to provide the salt concentrations in these measurements.

- On p. 9, the authors state that “We conclude that using 350mM NaCl yields conformational ensembles of the two IDPs and their phosphorylated forms which agree with SAXS and NMR data and thus resemble the experimental ensemble.” Is 350mM the concentration for which the agreement is best? Do the SAXS and NMR data both show the best agreement at the same concentration?

- What method was used to compute the chemical shifts? Can the authors provide error estimates for these shifts in Fig. 2? They state that the agreement is “very good” but without reporting error or the method used to compute the shifts, it is hard to assess this. Which salt concentration was used in the simulations reported in Fig. 2?

- p. 11, lines 191-193: The authors’ assessment of the accuracy of the C36m force field is problematic. They have carried out only a single simulation of 180 ns for 4 systems (~30 times less simulation than other systems). Despite the short simulation, they claim “In the case of Charmm36m, irrespective of the IDP and the phosphorylation, we observe a strong over collapse of the IDP which is not in line with the SAXS data and dominate over the charge effect.” This statement isn’t supported by the data.

- The paper would benefit from a systematic analysis of salt bridges, rather than relying on Rg (a global structural property) to infer effects on local structure, like salt bridges.

- p. 14, line 234: The authors refer to “the hydrodynamic radius”, but no RH is reported, so I think this must be a typo.

- p. 15, line 259: The authors suggest that the plot shown in Fig. 4 has a V-shape, but given the large error, this isn’t well-supported by the results.

- Fig. 5 is unclear and difficult to interpret.

- It is unclear how the equilibration of the simulations was treated. E.g. in Fig. S4, the authors exclude 40 ns for equilibration, but the reason for this decision wasn’t clear. Was 40 ns used for all systems? If so, why?

- Have the authors compared to all available experimental data for these systems?

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Computational Biology data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: No: Numerical data for the figures has not been provided.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions, please see http://journals.plos.org/compbiol/s/submission-guidelines#loc-materials-and-methods

Revision 1

Attachments
Attachment
Submitted filename: ResponseToReviewer.docx
Decision Letter - Alexander MacKerell, Editor, Arne Elofsson, Editor

Dear Dr. Gräter,

We are pleased to inform you that your manuscript 'How multisite phosphorylation impacts the conformations of intrinsically disordered proteins' has been provisionally accepted for publication in PLOS Computational Biology.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. 

Best regards,

Alexander MacKerell

Associate Editor

PLOS Computational Biology

Arne Elofsson

Deputy Editor

PLOS Computational Biology

***********************************************************

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The authors have addressed all the comments and the paper was very good and solid anyway.

Reviewer #2: The authors have addressed the comments of both reviewers. To reiterate my first review, the authors' study is carefully done and represents an important contribution to the field of disordered proteins. I recommend that it be published.

**********

Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: None

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Computational Biology data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Formally Accepted
Acceptance Letter - Alexander MacKerell, Editor, Arne Elofsson, Editor

PCOMPBIOL-D-20-02013R1

How multisite phosphorylation impacts the conformations of intrinsically disordered proteins

Dear Dr Gräter,

I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Katalin Szabo

PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom ploscompbiol@plos.org | Phone +44 (0) 1223-442824 | ploscompbiol.org | @PLOSCompBiol

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .